platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide

C34H42N4Pt — CID 140677112

IUPACplatinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide
SMILES[2H]C([2H])(N1[CH-]N(c2[c-]cccc2)C2=C1C(C)(C)CC2(C)C)C([2H])([2H])N1[CH-]N(c2[c-]cccc2)C2=C1C(C)(C)CC2(C)C.[Pt+4]
InChIInChI=1S/C34H42N4.Pt/c1-31(2)21-33(5,6)29-27(31)35(23-37(29)25-15-11-9-12-16-25)19-20-36-24-38(26-17-13-10-14-18-26)30-28(36)32(3,4)22-34(30,7)8;/h9-15,17,23-24H,19-22H2,1-8H3;/q-4;+4/i19D2,20D2;
InChIKeyNTNGAMYWHPNJOJ-SQQDPHQFSA-N
MW705.84 g/mol
LogP7.80
Rot. Bonds5

About platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide

platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide (PubChem CID 140677112) has the molecular formula C34H42N4Pt and a molecular weight of 705.84 g/mol. Its IUPAC name is platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide.

Molecular Properties

Compound Nameplatinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide
PubChem CID140677112
Molecular FormulaC34H42N4Pt
Molecular Weight705.84 g/mol
Exact Mass705.33
IUPAC Nameplatinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide
SMILES[2H]C([2H])(N1[CH-]N(c2[c-]cccc2)C2=C1C(C)(C)CC2(C)C)C([2H])([2H])N1[CH-]N(c2[c-]cccc2)C2=C1C(C)(C)CC2(C)C.[Pt+4]
InChIInChI=1S/C34H42N4.Pt/c1-31(2)21-33(5,6)29-27(31)35(23-37(29)25-15-11-9-12-16-25)19-20-36-24-38(26-17-13-10-14-18-26)30-28(36)32(3,4)22-34(30,7)8;/h9-15,17,23-24H,19-22H2,1-8H3;/q-4;+4/i19D2,20D2;
InChIKeyNTNGAMYWHPNJOJ-SQQDPHQFSA-N
XLogP7.80
TPSA12.96 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500705.84
LogP ≤ 57.80
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide?
The IUPAC name of platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide (CID 140677112) is platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide.
What is the SMILES notation for platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide?
The canonical SMILES for platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide is [2H]C([2H])(N1[CH-]N(c2[c-]cccc2)C2=C1C(C)(C)CC2(C)C)C([2H])([2H])N1[CH-]N(c2[c-]cccc2)C2=C1C(C)(C)CC2(C)C.[Pt+4].
What is the InChIKey of platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide?
The InChIKey is NTNGAMYWHPNJOJ-SQQDPHQFSA-N. The full InChI is InChI=1S/C34H42N4.Pt/c1-31(2)21-33(5,6)29-27(31)35(23-37(29)25-15-11-9-12-16-25)19-20-36-24-38(26-17-13-10-14-18-26)30-28(36)32(3,4)22-34(30,7)8;/h9-15,17,23-24H,19-22H2,1-8H3;/q-4;+4/i19D2,20D2;.
What are the key properties of platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide?
platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide has a molecular weight of 705.84 g/mol, XLogP of 7.80, 5 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for platinum(4+);4,4,6,6-tetramethyl-1-phenyl-3-[1,1,2,2-tetradeuterio-2-(4,4,6,6-tetramethyl-1-phenyl-2,5-dihydrocyclopenta[d]imidazol-2-id-3-yl)ethyl]-2,5-dihydrocyclopenta[d]imidazol-2-ide is sourced from PubChem (CID 140677112), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).